AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV)
FDA warns on increased mortality risk with AbbVie's Venclexta
The FDA issues a warning to healthcare professionals, oncology investigators and patients about the increased mortality risk for multiple myeloma sufferers who may receive AbbVie's ( ABBV +0.7% ) Venclexta (venetoclax) if participating in clinical studies. The FDA's action is based on da…
Abbvie - Not A Swan, But A Steal At Its Current Price.
AbbVie ( ABBV ) is one of the world's most interesting manufacturer's of medicine due to its history and future prospects. Some may argue that it presents too much of a risk for investment given its limited diversification, even for a risk-tolerant dividend investor. I will argue in this thesi…
Gilead (GILD): why this stock is undervalued
Gilead stock looks slightly undervalued at this point because the market is undervaluing Gilead’s HIV and oncology portfolios. What is the potential for this stock?
AbbVie (ABBV): Will The Stock Recover?
ABBV diverted the Rova-T program today—and that led to its stock price fall by 13%. When will the stock bounce back?